Remove Agriculture Remove CBD Remove DEA Remove Extraction
article thumbnail

Hemp Litigation: DEA Sued Again

Canna Law Blog

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule.

DEA 93
article thumbnail

The Hemp Industry Responds to the DEA Rule With a Lawsuit

Canna Law Blog

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. Emphasis added).

DEA 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DEA Attempts To Regulate CBD Processing

Greenspoon Marder Cannabis Law Group Blog

Drug Enforcement Administration (“DEA”) published an interim final rule surrounding hemp and hemp derivatives. In fact, most state departments of agriculture allowing for hemp cultivation under the 2014 Farm Bill expressly refused to regulate hemp processing. By: Nabil Rodriguez. Last week on Thursday August 20, 2020, the U.S.

DEA 40
article thumbnail

Kelley Drye: CBD and Hemp Legal and Regulatory Roundup – July 2021 #1

Cannabis Law Report

Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD. Congressional report offers overview of CBD/hemp market, policy challenges. However, CRS notes some observers suggest “a separate, marketable category exists for the plant’s extracted compounds” such as CBD oil. Marijuana Moment.

Hemp 105
article thumbnail

USA Dept of Justice Press Release: DEA Announces Steps Necessary to Improve Access to Marijuana Research

Cannabis Law Report

DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. The Agriculture Improvement Act of 2018, which was signed into law on Dec. Office of Public Affairs. FOR IMMEDIATE RELEASE.

DEA 59
article thumbnail

CBD: Everything You Need to Know

CannaMD

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD 99
article thumbnail

FDA Guidance on Cannabis Research: A Glimpse of What’s To Come for CBD Products?

Canna Law Blog

Although the guidance does not cover other FDA-regulated products, such as hemp-derived CBD (“Hemp CBD”)-infused foods and dietary supplements, the last section of the document – Section III C. The guidance provides that those using hemp raw material in their drug development activities should follow the U.S.

CBD 92